Reports for NOVARTIS PHARMACEUTICALS CANADA INC
Company Name
NOVARTIS PHARMACEUTICALS CANADA INC
Totals |
||
Shortage reports |
150 |
|
| Actual shortage: | 4 (3%) | |
| Anticipated shortage: | 3 (2%) | |
| Avoided shortage: | 4 (3%) | |
| Resolved: | 139 (93%) | |
Discontinuation Reports |
51 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 51 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
34 (17%) |
|
Overdue reports |
1 (14%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| NEVANAC | 0.1% | SUSPENSION | Resolved | 2018-03-26 | 2018-04-13 | 44006 |
| DUREZOL | 0.05% | EMULSION | Resolved | 2018-04-18 | 2018-04-20 | 46280 |
| TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2018-03-13 | 2018-04-25 | 42773 |
| MAXITROL | 1MG 6000UNIT 3.5MG | OINTMENT | Resolved | 2018-03-26 | 2018-04-25 | 44012 |
| VOLTAREN RAPIDE | 50MG | TABLET | Resolved | 2018-02-15 | 2018-05-11 | 39940 |
| NEVANAC | 0.1% | SUSPENSION | Resolved | 2018-04-27 | 2018-05-25 | 47334 |
| BETOPTIC S | .25% | SUSPENSION | Resolved | 2018-04-27 | 2018-06-06 | 47338 |
| PATANOL | 0.1% | LIQUID | Resolved | 2018-06-01 | 2018-06-19 | 51067 |
| ALOMIDE | 0.1% | SOLUTION | Resolved | 2018-06-01 | 2018-06-19 | 51063 |
| VOLTAREN OPHTHA | 0.1% | SOLUTION | Resolved | 2018-03-26 | 2018-06-22 | 44018 |
| LOPRESOR SR 100MG | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-11-30 | 2018-06-28 | 31273 |
| AFINITOR | 7.5MG | TABLET | Resolved | 2018-05-24 | 2018-07-10 | 50215 |
| NEVANAC | 0.1% | SUSPENSION | Resolved | 2018-07-05 | 2018-07-21 | 54449 |
| ALOMIDE | 0.1% | SOLUTION | Resolved | 2018-06-22 | 2018-07-27 | 52770 |
| AZARGA | 0.5% 1.0% | SUSPENSION | Resolved | 2018-07-05 | 2018-07-27 | 54440 |
| ARZERRA | 1000MG | SOLUTION | Resolved | 2017-03-23 | 2018-09-27 | 4093 |
| DUREZOL | 0.05% | EMULSION | Resolved | 2018-08-28 | 2018-10-04 | 59387 |
| ARZERRA | 100MG | SOLUTION | Resolved | 2017-03-23 | 2018-10-17 | 4096 |
| CILOXAN | 0.3% | SOLUTION | Resolved | 2018-09-28 | 2018-10-17 | 62545 |
| ALOMIDE | 0.1% | SOLUTION | Resolved | 2018-08-15 | 2018-10-18 | 58228 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ONBREZ BREEZHALER | 75MCG | CAPSULE | Discontinued | 2022-06-29 | 2022-07-14 | 163678 |
| ZOFRAN | 4MG | SOLUTION | Discontinued | 2022-06-29 | 2022-10-18 | 163685 |
| BETOPTIC S | 0.25% | SUSPENSION | Discontinued | 2022-09-28 | 2023-01-19 | 170389 |
| FORADIL DRY POWDER CAPSULES FOR INHALATION | 12MCG | CAPSULE | Discontinued | 2022-10-18 | 2023-01-25 | 172087 |
| ZOFRAN | 8MG | TABLET | Discontinued | 2023-04-13 | 2023-05-08 | 189538 |
| ZOFRAN | 4MG | TABLET | Discontinued | 2023-04-13 | 2023-05-08 | 189513 |
| LIORESAL INTRATHECAL 0.5MG/ML | 0.5MG | SOLUTION | Discontinued | 2023-08-17 | 2023-09-19 | 202298 |
| LIORESAL INTRATHECAL 0.05MG/ML | 0.05MG | SOLUTION | Discontinued | 2023-08-10 | 2023-09-19 | 201576 |
| LIORESAL INTRATHECAL 2MG/ML | 2MG | SOLUTION | Discontinued | 2023-08-10 | 2023-09-19 | 201573 |
| TASIGNA | 50MG | CAPSULE | Discontinued | 2023-10-19 | 2023-11-06 | 207564 |
| SANDOSTATIN | 100MCG | SOLUTION | Discontinued | 2024-03-22 | 2024-03-22 | 223070 |